Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Commun (Camb) ; 56(14): 2186-2189, 2020 Feb 18.
Article in English | MEDLINE | ID: mdl-31971182

ABSTRACT

The intrinsic l-DNA binding properties of a natural DNA polymerase was discovered. The binding affinity of Dpo4 polymerase for l-DNA was comparable to that for d-DNA. The crystal structure of Dpo4/l-DNA complex revealed a dimer formed by the little finger domain that provides a binding site for l-DNA.


Subject(s)
DNA-Directed DNA Polymerase/chemistry , DNA/chemistry , Crystallography, X-Ray , DNA/metabolism , DNA-Directed DNA Polymerase/metabolism , Models, Molecular , Protein Conformation
2.
Bioorg Med Chem Lett ; 29(16): 2189-2196, 2019 08 15.
Article in English | MEDLINE | ID: mdl-31270017

ABSTRACT

Homoharringtonine, known as omacetaxine mepesuccinate, is a pharmaceutical drug substance approved for treatment of chronic myeloid leukemia. Here, we report that homoharringtonine (HHT) is a novel chemical inhibitor of NRF2. HHT significantly suppressed NRF2 and ARE-dependent gene expression in human lung carcinoma A549 cells. HHT stabilized secondary structure of guanine-rich sequence existing in the 5'-untranslated region (5'-UTR) of Nrf2 and sensitized A549 cells to etoposide-induced apoptosis. To the best of our knowledge, HHT is the first type of transcriptional inhibitor of Nrf2 that stabilizes guanine-rich sequence existing in the 5'-UTR. Our study also provides a novel mechanism of action underlying how HHT exerts anti-carcinogenic effects in cancer cells.


Subject(s)
5' Untranslated Regions/genetics , Antineoplastic Agents, Phytogenic/therapeutic use , Guanine/chemistry , Homoharringtonine/therapeutic use , NF-E2-Related Factor 2/genetics , Antineoplastic Agents, Phytogenic/pharmacology , Homoharringtonine/pharmacology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...